XML 29 R5.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - BRL (R$)
R$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
OPERATING ACTIVITIES      
Income (loss) from continuing operations R$ (3,090,678) R$ 517,314 R$ 1,524,997
Adjustments for:      
Depreciation and amortization 1,777,703 1,715,863 1,517,402
Depreciation and depletion of biological assets 1,214,002 1,030,491 876,976
Result on disposal of property, plant and equipments and investment 3,985 (141,211) 40,220
Write-down of inventories to net realizable value 56,337 128,680 122,082
Provision for tax, civil and labor risks 341,038 116,144 319,237
Impairment 10,160
Income from investments under the equity method (1,076)
Financial results, net 2,668,755 3,044,575 1,698,995
Tax recoveries and gains in tax lawsuits (39,547) (108,785) (379,087)
Deferred income tax 208,060 (807,744) (250,136)
Employee profit sharing (10,190) 170,425 283,065
Other provisions [1] 554,460 2,793 61,185
 Cash flow provided by operating activities before working capital 3,682,849 5,668,545 5,825,096
Trade accounts receivable (144,597) 386,889 (481,192)
Inventories 712,913 (2,878,507) (2,622,702)
Biological assets - current (296,934) (815,699) (524,414)
Trade accounts payable (523,200) 1,420,014 2,154,693
Supply chain finance (843,467) 790,946 620,232
Cash generated by operating activities 2,587,564 4,572,188 4,971,713
Investments in securities at FVTPL [2] (675,897) (115,041)
Redemptions of securities at FVTPL [2] 679,990 145,053 102,172
Interest received 281,989 106,388 87,334
Payment of tax, civil and labor provisions (292,385) (399,252) (269,820)
Derivative financial instruments (1,191,475) 266,491 923,709
Payment of income taxes (155)
Other operating assets and liabilities 486,598 (652,191) 24,216
Net cash provided by operating activities 1,876,384 3,923,636 5,839,169
INVESTING ACTIVITIES      
Investments in securities at amortized cost (289,021) (4,060)
Redemptions of securities at amortized cost 290,132 166,112
Investments in securities at FVTOCI [3] (12,866)
Redemptions of securities at FVTOCI [3] 86,059 26,352
Redemption of restricted cash (2,074) 400 285,672
Additions to property, plant and equipment (1,452,733) (1,555,426) (804,609)
Additions to biological assets - non-current (1,387,669) (1,239,746) (1,006,222)
Proceeds from disposals of property, plant, equipments and investment 62,545 58,836 126,540
Additions to intangible assets (228,734) (179,632) (96,181)
Business combination, net of cash (158,348) (985,639)
Sale of participation in subsidiaries with loss of control 132,951 38,546
Capital increase in affiliates (92,885) 1,770 (1,087)
Net cash used in investing activities (3,258,787) (3,531,241) (1,430,989)
Net cash used in investing activities from discontinued operations (17,550)
Net cash used in investing activities (3,258,787) (3,548,791) (1,430,989)
FINANCING ACTIVITIES      
Proceeds from debt issuance 3,392,613 2,990,782 10,420,333
Repayment of debt (3,984,422) (1,395,347) (10,247,359)
Payment of interest (1,518,301) (1,193,367) (1,421,539)
Payment of interest derivatives - fair value hedge (252,662) (2,975)
Capital increase through issuance of shares (note 22.1) 5,275,444
Treasury shares acquisition (27,721) (106,070)
Acquisition of non-controlling interests (7,288) (238,421) (100,390)
Payment of lease liabilities (649,846) (705,427) (553,556)
Net cash provided by (used in) financing activities 2,255,538 (572,476) (2,008,581)
EFFECT OF EXCHANGE RATE VARIATION ON CASH AND CASH EQUIVALENTS (271,026) 149,826 939,241
Net increase (decrease) in cash and cash equivalents 602,109 (47,805) 3,338,840
Balance at the beginning of the year 7,528,820 7,576,625 4,237,785
Balance at the end of the year R$ 8,130,929 R$ 7,528,820 R$ 7,576,625
[1] Includes the amount of R$588,774 relating to the Leniency Agreement and other expenses related to investigations (note 1.3).
[2] FVTPL: Fair Value Through Profit and Loss.
[3] FVTOCI: Fair Value Through Other Comprehensive Income.